Journey Medical Corporation (DERM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Journey Medical Corporation, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$5.12
+3.23% today
Market cap
$140M
Overall quality
39/100
Kronos AI 30-day
+32.0%
8 of 8 simulated paths end higher
Journey Medical Corporation (DERM) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $140M. It trades at $5.12, up 3.23% today. Its overall quality score is 39 out of 100, ranked against the whole US market. 2 analysts' average target of $13.50 implies +163.7% from today's price. Kronos AI's 30-day forecast is +32.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $13.50 |
| Low – high | $13.00 – $14.00 |
| Analysts | 2 |
| Upside to average | +163.7% |
Kronos AI 30-day forecast
| Expected close | $6.55 (+32.0%) |
| Likely range | +22.6% … +42.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 26 |
| Solvency | 36 |
| Growth | 55 |
| Overall | 39 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.